Skip to main content

Research Repository

Advanced Search

All Outputs (100)

Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Myxomatous Mitral Valve Disease Receiving Pimobendan or Benazepril The QUEST Study
Journal Article
Haggstrom, J., Boswood, A., O'Grady, M., Jons, O., Smith, S., Borgarelli, M., …DiFruscia, R. Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Myxomatous Mitral Valve Disease Receiving Pimobendan or Benazepril The QUEST Study. https://doi.org/10.2377/0023-2076-59-117

Improving outcomes of myxomatous mitral valve disease in dogs
Journal Article
Boswood, A. (2018). Improving outcomes of myxomatous mitral valve disease in dogs. In Practice, 40(1), 12-15. https://doi.org/10.1136/inp.k915

Now that treatment has been shown to slow the onset of clinical signs of myxomatous mitral valve disease (MMVD), recommendations are focusing on diagnosing the condition before clinical signs manifest so that dogs can be maintained free of signs for... Read More about Improving outcomes of myxomatous mitral valve disease in dogs.

Circulating natriuretic peptides in cats with heart disease
Journal Article
Connolly, D. J., Magalhaes, R. J. S., Syme, H. M., Boswood, A., Fuentes, V. L., Chu, L., & Metcalf, M. Circulating natriuretic peptides in cats with heart disease. Journal of Veterinary Internal Medicine, 22(1), 96-105. https://doi.org/10.1111/j.1939-1676.2007.0024.x

Background: Circulating natriuretic peptide concentrations are increased in cats with myocardial dysfunction. Hypothesis: Serum N-terminal fragment of proatrial natriuretic peptide (NT-proANP) and NT-probrain natriuretic peptide (proBNP) concentratio... Read More about Circulating natriuretic peptides in cats with heart disease.